In vitro study of staphylococci susceptibility to gatifloxacin.

Author: BuiucD, PoiatăAntonia, TuchiluşCristina

Paper Details 
Original Abstract of the Article :
Gatifloxacin is in a class of drug called fluoroquinolone antibiotics. It eliminates bacteria that cause many infections, such as pneumonia and bronchitis, sinus, respiratory tract and urinary tract infections and sexually transmitted diseases. Gatifloxacin ophthalmic solution is used to treat bacte...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/17983195

データ提供:米国国立医学図書館(NLM)

Gatifloxacin: A Fluoroquinolone Antibiotic with Broad Spectrum Activity

Gatifloxacin is a fluoroquinolone antibiotic that has a wide range of activity against various bacterial species. This study investigates the susceptibility of staphylococci to gatifloxacin in vitro.

Gatifloxacin's Effectiveness: A Laboratory Study

The in vitro study demonstrated that gatifloxacin exhibits significant activity against staphylococci. This finding suggests that gatifloxacin may be a valuable treatment option for staphylococcal infections.

Combatting Infections: A Crucial Role for Antibiotics

Antibiotics play a crucial role in combating bacterial infections, and the development of new antibiotics with broad-spectrum activity is essential to address the growing challenge of antibiotic resistance.

Dr.Camel's Conclusion

Like a desert traveler relying on a well-stocked camel to carry essential supplies, patients facing bacterial infections depend on effective antibiotics to combat the invaders. This study adds to our understanding of gatifloxacin's effectiveness against staphylococci, highlighting its potential as a valuable weapon in our fight against infectious diseases.

Date :
  1. Date Completed 2008-02-06
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

17983195

DOI: Digital Object Identifier

17983195

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.